Feifei Na
Impact in
-
- Cancer, Hypoxia, and Metabolism
-
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
Papers in
- Oncology 16
- Cancer Immunotherapy and Biomarkers 6
- Cancer Cells and Metastasis 3
- Lung Cancer Research Studies 3
-
- Protein Degradation and Inhibitors 2
- Angiogenesis and VEGF in Cancer 2
- Co-authors
- Jianxin Xue (14 shared papers)You Lü (8 shared papers)Lei Deng (8 shared papers)Cong Li (1 shared paper)Jingwen Wang (2 shared papers)Chong Chen (6 shared papers)Jingyao Chen (3 shared papers)Jie Lan (5 shared papers)
- Journals
- Biomedicine & Pharmacotherapy (2 papers)Journal of Clinical Oncology (2 papers)Frontiers in Oncology (2 papers)Radiotherapy and Oncology (2 papers)Cancer Letters (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Feifei Na
31 papers receiving 645 citations
Peers
Comparison fields: 5 of 72
- Cancer Research 98
- Oncology 149
- Pulmonary and Respiratory Medicine 171
- Immunology 102
- Hepatology 35
Countries citing papers authored by Feifei Na
This map shows the geographic impact of Feifei Na's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei Na with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei Na more than expected).
Fields of papers citing papers by Feifei Na
This network shows the impact of papers produced by Feifei Na. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei Na. The network helps show where Feifei Na may publish in the future.
Co-authors
The 25 scholars most cited alongside Feifei Na, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 125 | |
| 2 | 2017 | 95 | |
| 3 | 2020 | 77 | |
| 4 | 2022 | 37 | |
| 5 | 2020 | 32 | |
| 6 | 2017 | 28 | |
| 7 | 2013 | 26 | |
| 8 | 2013 | 24 | |
| 9 | 2015 | 22 | |
| 10 | 2022 | 20 | |
| 11 | 2023 | 17 | |
| 12 | 2022 | 17 | |
| 13 | 2023 | 15 | |
| 14 | 2022 | 14 | |
| 15 | 2018 | 13 | |
| 16 | 2023 | 13 | |
| 17 | 2023 | 11 | |
| 18 | 2018 | 11 | |
| 19 | 2014 | 10 | |
| 20 | 2024 | 9 |
About Feifei Na
Feifei Na is a scholar working on Oncology, Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine and Surgery, having authored 34 papers that have together received 651 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Cancer, Hypoxia, and Metabolism (4 papers), Cancer Cells and Metastasis (3 papers), Lung Cancer Research Studies (3 papers), Protein Degradation and Inhibitors (2 papers), Immune cells in cancer (2 papers), Esophageal Cancer Research and Treatment (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). The work is most often cited by research in Cancer Research (98 citations), Oncology (149 citations), Pulmonary and Respiratory Medicine (171 citations), Immunology (102 citations) and Hepatology (35 citations). Feifei Na has collaborated with scholars based in China and United States. Frequent co-authors include Jianxin Xue, You Lü, Lei Deng, Cong Li, Jingwen Wang, Chong Chen, Jingyao Chen, Jie Lan, Wei Wang and Fei Mo. Their work appears in journals such as Biomedicine & Pharmacotherapy, Journal of Clinical Oncology, Frontiers in Oncology, Radiotherapy and Oncology and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.